Depo-Provera MDL Court Filings & CMOs

Pfizer, the manufacturer of the injectable contraceptive Depo-Provera, is currently facing lawsuits alleging a link between long-term use of the drug (and its generic equivalents) and the development of meningioma — tumors that form on the tissue lining the brain and spinal cord.

As of now, 22 cases have been filed across eight different federal district courts. Plaintiffs argue that Pfizer failed to adequately warn users of the neurological risks associated with Depo-Provera.

A motion has been filed to consolidate these cases into a Multidistrict Litigation (MDL), with a proposed transfer to the Northern District of California. This venue is being considered under the principle of innovator liability, which allows claims to proceed against brand-name manufacturers even when the injured party took a generic version of the drug.

Below are the currently available filings related to this ongoing litigation:

Depo-Provera MDL Case Filings

• 11/26/2024: Memorandum in Support of Motion for Transfer to Create MDL [PDF]
• 02/07/2025: Pretrial Order No. 1 – Assignment of Magistrate Judge Hope T. Cannon [PDF]
• 02/11/2025: Pretrial Order No. 2 – Case Management Procedures and Pleading Extensions [PDF]
• 02/12/2025: Pretrial Order No. 3 – Notice of In-Person Attendance for Initial Case Management Conference [PDF]
• 02/13/2025: Pretrial Order No. 4 – Docketing and Filing Procedures [PDF]
• 02/23/2025: Case Management Order No. 1 – Initial Case Management Conference & Pilot Case Selection [PDF]
• 02/28/2025: Leadership Application Form – Plaintiff Counsel Information Sheet [PDF]
• 03/01/2025: Pretrial Order No. 6 – Appointment of Data Administrator[PDF]
• 03/01/2025: Pretrial Order No. 7 – Appointment of Special Master[PDF]
• 03/09/2025: Pretrial Order No. 8 – Plaintiff Leadership Presentations[PDF]
• 03/11/2025: Pretrial Order No. 9 – Appointment of Common Benefit Special Master[PDF]
• 03/11/2025: Common Benefit Order No. 1 – Preliminary Procedures & Fee Guidelines [PDF]
• 03/13/2025: Pretrial Order No. 10 – Stipulated Order on Procedures for Direct Filing[PDF]
• 03/14/2025: Pretrial Order No. 11 – Stipulated Order Governing Confidentiality [PDF]
• 03/14/2025: Pretrial Order No. 12 – Stipulated Order on MDL Centrality Service [PDF]
• 03/14/2025: Pretrial Order No. 13 – Governing Production of Documents and ESI [PDF]
• 03/14/2025: Pretrial Order No. 14 – Pfizer ESI Search & Validation Protocol [PDF]
• 03/14/2025: Pretrial Order No. 15 – MDL Centrality Portal Activation [PDF]
• 03/14/2025: Pretrial Order No. 16 – Deposition Protocol [PDF]
• 03/14/2025: Pretrial Order No. 17 – Threshold Proof of Use & Injury Requirements [PDF]
• 03/14/2025: Plaintiff Proof of Use/Injury Questionnaire [PDF]
• 03/15/2025: Case Management Order No. 2 – Summary of Second CMC, Rule 26 Report Issues & Pilot Case Updates [PDF]
• 03/15/2025: Pilot Case Scheduling Order – Discovery, Preemption, and Expert Deadlines [PDF]
• 03/16/2025: Pretrial Order No. 18 – Plaintiff and Defense Leadership Appointments [PDF]
• 03/27/2025: Pretrial Order No. 19 – ESI Protocol for Prasco LLC Document Production [PDF]
• 03/27/2025: Pretrial Order No. 20 – ESI Protocol: Greenstone & Viatris Document Production [PDF]
• 04/03/2025: Pretrial Order No. 21 – New Updates & Procedural Directives [PDF]
• 04/21/2025: Court Order – Authorized Generic Defendants Not Required to Sit for Depositions [PDF]
• 05/06/2025: Proof of Use and Injury Review Process [PDF]
• 05/12/2025: Pretrial Order No. 23 – Identification of Deficiencies in Complaints [PDF]
• 05/12/2025: Exhibit A – Complaint Deficiency Review Process Protocol [PDF]
• 05/12/2025: Exhibit B – Standardized Direct-Filed Complaint Template [PDF]
• 05/12/2025: Exhibit C – Standardized Complaint Template for Transferred Cases [PDF]

(More documents will be added as the case develops — bookmark this page to stay up to date.)

Depo-Provera Brain Tumor Lawsuit Information

To learn more about the connection between Depo-Provera and brain tumor risk, visit our Depo-Provera Brain Tumor Lawsuit information page.

For a free consultation with one of our Depo-Provera attorneys, call 202-792-7927.